Erwin L Roggen
Overview
Explore the profile of Erwin L Roggen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diemar M, Krul C, Teunis M, Busquet F, Kandarova H, Zajac J, et al.
Altern Lab Anim
. 2024 Dec;
53(1):42-61.
PMID: 39694026
The first ONTOX Hackathon of the EU Horizon 2020-funded ONTOX project was held on 21-23 April 2024 in Utrecht, The Netherlands (https://ontox-project.eu/hackathon/). This participatory event aimed to collectively advance innovation...
2.
Tsamou M, Kremers F, Samaritakis K, Roggen E
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273498
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) are chronic syndromes of unknown etiology, accompanied by numerous symptoms affecting neurological and physical conditions. Despite frequent revisions of the diagnostic criteria,...
3.
Pistollato F, Burkhart G, Deceuninck P, Bernasconi C, Di Virgilio S, Emili L, et al.
Front Public Health
. 2024 Aug;
12:1417684.
PMID: 39104886
In the past decade, significant European calls for research proposals have supported translational collaborative research on non-communicable and infectious diseases within the biomedical life sciences by bringing together interdisciplinary and...
4.
Kalyva M, Vist G, Diemar M, Lopez-Soop G, Bozada T, Luechtefeld T, et al.
Environ Pollut
. 2024 May;
352:124109.
PMID: 38718961
Exposure assessment is a crucial component of environmental health research, providing essential information on the potential risks associated with various chemicals. A systematic scoping review was conducted to acquire an...
5.
Tsamou M, Roggen E
Brain Res
. 2024 Feb;
1829:148791.
PMID: 38307153
Background: The onset and pathology of sporadic Alzheimer's disease (sAD) seem to be affected by both sex and genetic mechanisms. Evidence supports that the high prevalence of sAD in women,...
6.
Diemar M, Vinken M, Teunis M, Krul C, Busquet F, Zajac J, et al.
Altern Lab Anim
. 2024 Jan;
52(2):117-131.
PMID: 38235727
The first Stakeholder Network Meeting of the EU Horizon 2020-funded ONTOX project was held on 13-14 March 2023, in Brussels, Belgium. The discussion centred around identifying specific challenges, barriers and...
7.
Maertens A, Antignac E, Benfenati E, Bloch D, Fritsche E, Hoffmann S, et al.
ALTEX
. 2024 Jan;
41(2):273-281.
PMID: 38215352
Both because of the shortcomings of existing risk assessment methodologies, as well as newly available tools to predict hazard and risk with machine learning approaches, there has been an emerging...
8.
Tsamou M, Kalligerou F, Ntanasi E, Scarmeas N, Skalicky S, Hackl M, et al.
J Alzheimers Dis Rep
. 2023 Apr;
7(1):235-248.
PMID: 37090956
Background: Late-onset or sporadic Alzheimer's disease (sAD) is a neurodegenerative disease leading to cognitive impairment and memory loss. The underlying pathological changes take place several years prior to the appearance...
9.
Tsamou M, Roggen E
J Alzheimers Dis Rep
. 2022 Jul;
6(1):271-296.
PMID: 35891639
The adverse outcome pathway (AOP) concept was first proposed as a tool for chemical hazard assessment facilitating the regulatory decision-making in toxicology and was more recently recommended during the BioMed21...
10.
Tsamou M, Carpi D, Pistollato F, Roggen E
J Alzheimers Dis
. 2022 Feb;
86(3):1427-1457.
PMID: 35213375
Background: A complex network of aging-related homeostatic pathways that are sensitive to further deterioration in the presence of genetic, systemic, and environmental risk factors, and lifestyle, is implicated in the...